The Optimum Omega-3 (003) Diet Study

Completed · Not applicable

Conditions studied: Stress, Physiological

In brief

The goal of the Optimum Omega-3 (OO3) Diet Study is to assess whether swapping specific food ingredients in diets can significantly change omega-3 blood profiles with 10 weeks of a 7-day menu in men and women (18-40 years old). We want to look at the effect on a person's response to cognition, satiety and physical fitness. Investigators think that low omega-6 and moderate omega-3 fatty acid diets may regulate emotional response and help to return to normal after load carrying activities. We plan to test the effects of improving overall fatty acids on emotional response, satiety, and physical fitness levels by a diet with an improved omega-3 to omega-6 diet compared to a control diet.

Key facts

Study ID

NCT01642368

Run by

Pennington Biomedical Research Center

People needed

8

Starts

2012-06-01

Expected to finish

2013-11-01

Last updated by the study team

2019-03-20

Who can join

Age: 18 and older, up to 40. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• 18-40 years of age
• Healthy and able to perform all requirements of the study without injury.
• Body Mass Index (BMI), >18 and <30 Kg/m2 (BMI is a measure of your height and weight ratio.
• No history of cardiac problems or evidence of current heart problems.
• willing to use effective method of birth control if you are capable of bearing children.
• willing to consume menus for 10 consecutive weeks.
• willing to complete all study-related activities.
• If you are taking dietary supplements, you are willing to discontinue their use during the study.
• willing to follow the alcohol consumption restrictions during the study.
• Have access to a personal microwave and refrigerator to keep foods at the proper temperature for storage and consumption.

You may not qualify if…

• Have a history of gall stones or any other significant metabolic, blood, lung, neurologic (nervous system), immune, liver, kidney, or urologic (urinary system) disorders.
• Have any disease or condition that seriously affects body weight and/or body composition.
• Practice a vegan or vegetarian dietary lifestyle.
• Are gluten intolerant (allergic reaction to wheat products)
• Have a history of short-term (less than a month) treatment woth steroids within six months prior to randomization into the 003 Diet Study.
• Require regular use of medications that ma interfere with the study (other than contraceptives or other medications that have been on a stable dose for 6 months prior to the study). the study staff will review all medication criteria with you.
• Have diabetes.
• Have a history or evidence of significant gastrointestinal dysfunction.
• Chronically use laxatives, The use of stool softeners is acceptable. Use of bulking agents, if required, should remain constant.
• Have abnormal blood or urine results.
• Have evidence or recurrence of cancers within the past five years if it is thought to interfere with study participation, other than some skin cancers.
• Anticipate surgery during the study period.
• Donated blood during the month prior to study entry or plan to during the study.
• Have participated in other studies using an investigational drug during the preceding 3 months.
• Have had a fluctuation in body weight >10% (or about 15 lbs) in the preceding 2 months.
• Are taking prescription or over the counter medication or supplements for desired weight loss.
• Are taking prescription or over the counter medication or supplements for desired weight loss.
• Drink more than 4 alcoholic drinks daily or 6 on one occasion more than once a month within the past 6 months.
• Currently using cocaine, amphetamines, or other illicit substances.
• Have a psychiatric disorder that would interfere with your ability to complete the study.
• Are claustrophobic.
• Have a history of post-traumatic stress disorder, anxiety or panic attack disorders, or other psychological/fear/or anxiety disorders.
• Are unwilling or unable to follow the rigors of the data collection and clinical evaluation schedule over the study period.
• Are pregnant, breast feeding or planning to become pregnant before the end of the study.
• Are unwilling to be assigned at random to any intervention group.

Where it is running

• Pennington Biomedical Research Center — Baton Rouge, Louisiana, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.